Which MPN Treatment Is Right for You? What You Need to Know
What should you know before deciding which treatment is best for YOUR MPN? MPN expert Dr. John Mascarenhas reviews key factors--including essential testing--that guide treatment decisions for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr. Mascarenhas also provides an overview of available treatment types and why he’s hopeful about the future of MPN research. Dr. John Mascarenhas is Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and the Director of the Adult Leukemia Program and Leader of Clinical Investigation within the Myeloproliferative Disorders Program at Mount Sinai. Learn more about Dr. Mascarenhas, here: https://www.mountsinai.org/profiles/j.... Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: powerfulpatients.org/connect

A Conversation with an MPN Specialist: Essential Thrombocythemia

How to Play an Active Role in Your CLL Treatment Decisions

Progression in MPN from ET PV to MF - Steffen Koschmieder

The French Do Not Care About Work

The Crystal That Could Destroy All Medicine

Lipoprotein(a): Who's Most at Risk

Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa

The "Fantastic Four" Differential In Thrombocytopenia

polycythaemia vera und ich

How I've Lived with an MPN Cancer for 33 Years | Diet, Exercise & Mental Health (Jeremy's MPN Story)

Invisible: Taja’s MPN Story

Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe

Your Legs Weaken First! Eat These 6 Foods to Strengthen Them FAST | William Li

Statins Exposed: Why the Evidence Doesn't Match the Hype

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026

May 2026 - Research Spotlight with Dr. DeMayo and Dr. Sochet

Recent advances in the diagnosis, prognosis and survival predictions of patients with PV

I Treat Cholesterol Differently Now: Statins, PCSK9s, Ezetimibe & Gene Editing

Essential Thrombocythemia Watch & Wait | What Patients Should Know
![Myeloproliferative Neoplasm [Hot Topic]](https://i.ytimg.com/vi/W305g1Tj8wQ/hqdefault.jpg?sqp=-oaymwE9CNACELwBSFryq4qpAy8IARUAAAAAGAElAADIQj0AgKJDeAHwAQH4Af4EgALgA4oCDAgAEAEYZSBlKGUwDw==&rs=AOn4CLBaaREzpa6RrPonFQbcucHl9z0i6w)
